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Abstract
A variety of compounds from medicinal plants have been reported to possess anti-
inflammatory properties. Selected natural compounds that exhibit anti-inflammatory 
properties were subjected to docking simulation using AutoDock Vina to investigate 
their interaction modes to the potential macromolecular targets. The docking was per-
formed using different molecular targets, i.e., cyclooxygenase-2, phospholipase A2, 
NF-κB inhibitor, and interleukin-1 receptor. It revealed that flavonoids have the highest 
affinity to the macromolecular targets (the lowest binding energy values) and the high-
est consistency of interaction model. Some terpenoids were identified to have potential 
inhibitor of phospholipase A2.
Keywords: molecular docking analysis, natural compounds, anti-inflammatory, 
Autodock Vina
1. Introduction
Inflammation is the body defense system in response to the pathogens and injury. During the 
inflammation process, various inflammatory mediators are synthesized and secreted from cells 
and generate many cellular effects [1]. Uncontrolled inflammation lead to several chronic dis-
eases such as cardiovascular disease, arthritis, asthma, type 2 diabetes mellitus, and cancer. To 
relieve inflammatory responses, nonsteroidal anti-inflammatory drugs (NSAIDs) and steroids 
are widely used. NSAIDs possess anti-inflammatory effect by inhibit cyclooxygenase (COX) 
enzyme. However, their long-term use causes gastrointestinal toxicity due to nonselective inhi-
bition of COX-1 and COX-2 [2]. Glucocorticoids decrease the transcription of proinflamma-
tory cytokines and chemokines and increase the transcription of anti-inflammatory cytokines, 
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resulting in strong anti-inflammatory activity. However, their benefits are limited by the vari-
ety of systemic side effects and the development of resistance after chronic use. Thus, develop-
ing new drug candidates from natural products is greatly interesting [3].
In medicinal plants, many natural compounds, such as flavonoids, terpenoids, alkaloids, and 
saponin, have been reported to have in vitro as well as in vivo anti-inflammatory activity 
[4]. The mechanism of action and molecular target of various natural compounds needs to 
be studied for constructing a structure activity relationship. Molecular docking analysis can 
be conducted to study the interaction of these natural compounds with various molecular 
targets of anti-inflammatory activity. Further, the structure-activity relationship can be used 
to develop new derivative natural compounds with higher anti-inflammatory activity. This 
research aims to determine the model of interactions between the natural compounds with 
anti-inflammatory molecular target by molecular docking analysis. These natural compounds 
were used as the subjects in this study, with the cyclooxygenase-2 (COX-2), phospholipase 
A2, NF-κB–inducing kinase (NIK), and interleukin receptor (IRAK) as the molecular targets. 
The molecular docking analysis was conducted using Autodock Vina.
2. Molecular targets of anti-inflammatory agents
2.1. Cyclooxygenase-2 (COX-2)
The COX enzymes (COX-1 and COX-2) catalyze the biosynthesis of prostaglandins, prosta-
cylins and thromboxanes, from arachidonic acid. COX-1 is constitutively expressed in most 
tissues, while COX-2 is expressed in specific tissues and is induced by cytokine and growth 
hormones. COX-1 possesses regulatory effects on platelet aggregation and gastric mucous 
biosynthesis, while COX-2 is involved in pathological conditions such as inflammation, pain, 
and fever. NSAIDs possess their anti-inflammatory activity by inhibition of COX-1 and COX-
2. Prolonged inhibition of COX-1 in the gastrointestinal system causes gastrointestinal tract 
injury due to ulcer formation and gastric bleeding. Coxibs, the COX-2 selective inhibitor, were 
designed to inhibit COX-2 over COX-1, to obtain desired anti-inflammatory activity with min-
imal gastric toxicity side effect [5].
COX-1 and COX-2 were almost identical, despite of the residues of Ile434, His513, and Ile523 
in COX-1, while in COX-2 were Val434, Arg513, and Val523. These differences result in a vol-
ume increasing of the COX-2 active site and additional side pocket off the main channel. The 
structures of coxibs consist of diaryl heterocycle with a sulfonamide or methyl sulfone moiety, 
which will bind to the side pocket of COX-2 to provide isoform-selective inhibition [6].
2.2. Phospholipase A2 (PLA2)
Phopholipase A2 (PLA2) enzymes are required to increase the level of arachidonic acid 
for metabolism and biosynthesis of eicosanoid under physiological condition as well as in 
inflammatory cell activation. PLA2 superfamily consists of cytosolic calcium dependent PLA2 
(cPLA2), cytosolic calcium-independent PLA2 (iPLA2), and secreted PLA2 (sPLA2). iPLA2 is 
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constitutively generating a low level of free fatty acids with relatively minimal specificity for 
the particular esterified fatty acid. cPLA2 hydrolysis arachidonic acid-containing phospholip-
ids, leading to the production of proinflammatory eicosanoids. sPLA2 is an inducible enzyme 
that augments cPLA2 function to control the magnitude and duration of elevated free fatty 
acid levels including arachidonic acid [7].
2.3. NF-κB–inducing kinase (NIK)
Nuclear factor (NF)-κB is a group of eukaryotic transcription factors that regulates the expres-
sion of gene important for immune responses. NF-κB-inducing kinase (NIK) activates NF-κB2 
by promoting proteolytic processing and the generation of NF-κB transcription of the targeted 
gene. NIK is also required in the signaling pathways elicited by other cytokines. NIK regu-
lates both inflammation-induced and tumor-associated angiogenesis. NIK is highly expressed 
in endothelial cells of tumor tissues and inflamed rheumatoid arthritis synovial tissues [8].
2.4. Interleukin-1 receptor-associated kinase-4 (IRAK-4)
Contribution of interleukin-1 (IL-1), a proinflammatory cytokine, in the inflammation net-
work is important. It propagates and amplifies signals; furthermore, the signaling pathways 
mediated by IL-1 and other cytokines receptors may communicate in various cross-talk 
mechanisms. Therefore, inhibition of IL-1 receptor would have profound effects on overall 
inflammatory responses. Interleukin-1 receptor-associated kinase 4 (IRAK-4) plays a pivotal 
role in signaling cascades associated with the immune and inflammatory diseases, and may 
be an effective therapeutic target for various diseases associated with deregulated inflam-
mation [9].
3. Anti-inflammatory activity of natural compounds
3.1. Flavonoid and phenolic compounds
Flavonoids belong to a group of natural compounds and occur as aglycone, glycosides, and 
other derivatives. The flavonoids are categorized into flavonols, flavones, cathecins, flava-
nones, anthocyanidins, and isoflavonoids. Flavonoids exert their anti-inflammatory activity 
by various mechanisms, i.e., inhibition of phospholipase A2, COX, and LOX. Other mecha-
nisms include inhibition of histamine release, phosphodiesterase, protein kinases, and activa-
tion of transcriptase. Phenylated flavonoids and a number of biflavonoids (amentoflavone, 
bilobetin, morelloflavone and ginkgetin) have been shown to inhibit phospholipase C1 and 
A2. Quercetin is reported as a strong inhibitor of both COX-2 and 5-LOX [10].
Curcumin, a polyphenol compound derived from the rhizomes of the plant turmeric, has 
anti-inflammatory activity, mainly due to inhibition of arachidonic acid (AA) metabolism, 
cyclooxygenase (COX), lipoxygenase (LOX), cytokines interleukin (IL) and tumor necrosis 
factor (TNF), and nuclear factor kappa B (NF-κB), despite it is also reported to stabilize lyso-
somal membranes [11–14].




Terpenoids are classified into hemi-, mono-, sesqui-, di-, sester-, tri- and tetraterpenoids. 
A large numbers of terpenoids have been tested for anti-inflammatory properties. Anti-
inflammatory activity of 1,8-Cineol, a monoterpene oxide, is correlated to inhibition of leu-
kotriene B4, prostaglandin E2 TNF-α, interleukin, and thromboxane [15]. Parthenolide, a sesquiterpene lactone, possesses anti-inflammatory activity by several mechanisms, includ-
ing inhibition of NF-κB [16]. Cucurbitacins, a group of triterpenes, were reported to show 
anti-inflammatory activity by inhibition of prostaglandin production and blocking NF-κB 
activation [17].
3.3. Alkaloid
Alkaloids are the basic substances that contain one or more nitrogen atoms, usually in com-
bination as part of a cyclic system. They are often toxic to have various pharmacological 
activities, including anti-inflammatory activity [18]. Isoquinoline, quinoline, and indole alka-
loids were the most studied classes for anti-inflammatory activity. Berberine, an isoquinoline 
alkaloid, showed potential in vitro and in vivo anti-inflammatory activity. It was reported 
to inhibit prostaglandin E2 production, without inhibitory effect on either COX-1 or COX-2 
activity [19].
3.4. Saponins
Saponins are group of glycosides found in many plants, with triterpenoid or steroid as the 
aglycone moiety. Kalopanaxsaponin A was triterpenoid saponin isolated from the stem bark 
of Kalopanax pictus that showed significant anti-inflammatory activity [20]. Loniceroside A, 
a triterpenoid saponin isolated from the aerial parts of Lonicera japonica, also showed com-
parable anti-inflammatory activity to aspirin. It exhibited anti-inflammatory activity against 
acute and chronic inflammation [21].
4. Molecular docking analysis
Molecular modeling investigations were carried out using Zyrex Cruiser workstation EM4100 
running Intel Core i3-4030U Processor, 2 GB RAM, 500 GB hard disk, and Intel HD Graphic 
Family graphics card. Autodock Vina docking program, Molecular Graphic Lab, The Scripps 
Research Institute [22] was employed for the docking studies.
4.1. Preparation of target proteins
PDB structures used, i.e., 5IKT (COX-2), 4UY1 (PLA2), 1DV4 (NF-κB), 5KX7 (IRAK-4), were 
obtained from the Brookhaven Protein Data Bank (www.rcsb.org). Table 1 presented the 
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Target macromolecule (pdb 
code)
Ligand Structure
COX-2 (5IKT) Tolfenamic acid







Table 1. Target macromolecules, pdb codes, native ligands, and ligand structures used in the docking study.
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 target macromolecules and each of the native ligand. The protein structures were prepared 
using UCSF Chimera 1.11.2 to remove all nonreceptor atom including water, ion, and miscel-
laneous compounds. The obtained structures then were saved as pdb file.
4.2. Preparation of ligands
The structures of native ligands from each target macromolecules were prepared by UCSF 
Chimera 1.11.2 to separate from the protein, water, and miscellaneous substances. The struc-
tures of the 40 ligands of natural compounds were sketched using MolView 2.2. Each struc-
ture then was executed an MMFF94 energy minimization. These obtained conformations 
were used as starting conformations to perform docking analysis.
4.3. Docking method validation
To ensure that the docking studies were valid and represented the reasonable potential bind-
ing model, the docking methods and parameters used were validated by redocking experi-
ment. Each copy of native ligand was docking into the native protein to determine the ability 
of Autodock program to reproduce the orientation and position of the ligand observed in the 
crystal structure. The valid criteria used is the all atom root mean square deviation (RMSD) 
between the docked position and the crystallographically observed binding position of the 
ligand, and success is typically regarded as being less than 2 Å.
4.4. Docking studies
Docking studies were carried out using the above mentioned prepared target macromolecules 
and natural compound ligands (1–40) by employing Autodock Vina program. Docking was 
performed to obtain a population of possible conformations and orientations for the ligand at 
the binding site. The protein was loaded in PyRx software, creating a PDBQT file that contains 
a protein structure with hydrogens in all polar residues. All bonds of ligands were set as rotat-
able. All calculations for protein-fixed ligand-flexible docking were done using the Lamarckian 
Genetic algorithm (LGA) method. The docking site on protein target was defined by establish-
ing a grid box with a default grid spacing, centered on the position of native ligand. The best 
conformation was chosen with the lowest binding energy, after the docking search completed. 
The interactions complex protein-ligand conformations, including hydrogen bonds and the 
bond lengths were analyzed using Discovery Studio Visualizer 16.1.0.15350.
5. Result and discussion
The molecular docking analysis was performed using Autodock Vina program with 40 plant-
derived compounds, including flavonoids and phenolic compounds, alkaloid, terpenoid, and 
saponin. First, the validation method was conducted to ensure the capability of docking machine. 
Figure 1 represented the validation result of docking protocol. All of the  redocking ligands showed 
similar conformation with the native redocking ligands, and the RMSD values were ≤2.0 Å.
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Each natural compound then was docked into each of six different targets, using valid param-
eter method. The lowest energy docked conformation of the best cluster was selected and 
analyzed. Table 2 summarizes the docking study results, presented as binding energy.
5.1. Interaction to Cyclooxygenase-2
Structure of COX-2 complex with tolfenamic acid, a selective COX-2 inhibitor, was used for this 
study. The carboxylic group of tolfenamic acid interacted by hydrogen bonding with Tyr-385A 
and Ser-530A at the top of channel. While the methylphenyl aminobenzoic moiety interacted 
hydrophobically with Val116A, Val349A, Leu352A, Val523A, Ala527A, as well as Leu531A [23]. 
This study revealed that some flavonoids and phenolic compounds, i.e., amentoflavone, apigenin, 
bilobetin, diosmine, epicatechin gallate, ginkgetin, hesperidin, luteolin, morelloflavon, and quer-
cetin, showed lower binding energy than that of tolfenamic acid, the selective COX-2 inhibitor.
The model interaction of these flavonoids to the binding site of COX-2 was similar to the 
model interaction of native ligand. Carbonyl group at C-ring of flavonoid played an important 
role in the ligand-target interaction, by hydrogen bond interaction to Ser530A and Arg120A 
residue, while A- and B-phenolic ring interacted to Val349A, Leu352, Ala527, and Leu531A 
residue via hydrophobic interaction (Figure 2).
This result was in line with previous reports about COX-2 inhibitory activity of flavonoid and 
phenolic compounds. Several research reports about COX inhibitory activity of flavonoids 
were documented [24–26]. A structure-activity relationship study about COX-2 inhibitory 
activity of flavonoid resumed the pharmacophores group were 4-oxo (C-ring), 7-hydroxyl 
moiety (A-ring), as well as para-substituted phenolic B-ring [27]. Apigenin meets all the 
requirements, due to its hydroxylation pattern at 5’-, 7’-, and 4’-positions.
Figure 1. Overlay of the native ligands (gray) and redocking conformations (yellow). (a: COX-2; b: PLA2; c: NF-κB; d: 
IRAK-4).
Molecular Docking Analysis: Interaction Studies of Natural Compounds to Anti-inflammatory Targets
http://dx.doi.org/10.5772/intechopen.68666
69
Compound Target macromolecules; binding energy (kcal/mole)
COX-2 PLA2 NIK IRAK-4
Native ligand −9.0 −7.8 −9.9 −9.0
Flavonoids and phenolic compounds:
Amentoflavone −8.7 −9.0 −8.2 −8.1
Anthocyanin −8.3 −7.8 −8.3 −8.1
Apigenin −9.2 −7.8 −9.1 −9.3
Apocynin −6.7 −6.5 −6.8 −6.3
Apocynin ester −6.2 −5.8 −6.0 −6.2
Bilobetin −10.6 −9.1 −6.3 −10.1
Curcumin −8.9 −8.4 −9.0 −9.3
Diosmine −8.6 −8.9 −5.6 −8.8
Epicatechin gallate −9.9 8.2 −7.9 −8.4
Epigallocatechin 
gallate
−8.4 8.1 −8.0 −8.8
Ginkgetin −9.4 −9.0 −6.4 −10.2
Hesperidin −8.8 −8.9 −6.1 −8.2
Hydrocinnamic acid −6.4 −6.6 −6.4 −6.8
Luteonin −9.4 −8.1 −9.3 −8.9
Morelloflavon −9.5 −8.1 −4.1 3.0
Paeonol −6.5 −6.0 −5.9 −6.1
Procyanidin −7.9 −8.5 −6.5 −4.9
Pterostilben −7.6 −6.7 −8.0 −8.0
Quercetine −9.5 −8.1 −8.9 −9.1
Resveratol −7.9 −7.1 −8.0 −8.1
Yuccaol A −7.8 −8.2 −6.4 0.3
Yuccaol B −8.0 −7.0 0.3 −0.8
Yuccaol C −7.8 −6.9 −0.4 −0.5
Yuccaol D −8.5 −7.5 −1.8 3.3
Yuccaol E −8.1 −7.1 −0.9 −1.0
Alkaloids
Berberine −9.8 −8.4 −8.9 −9.3
Terpenoids
1.8-Cineol −5.6 −5.2 −5.8 −5.9
Cucurbitacin B −8.0 −7.6 −2.1 −0.6
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Compound Target macromolecules; binding energy (kcal/mole)
COX-2 PLA2 NIK IRAK-4
Cucurbitacin D −8.2 −7.4 −3.3 −1.7
Cucurbitacin E −8.8 −7.8 −2.9 −3.3
Cucurbitacin I −8.4 −7.3 −3.7 −3.0
Cucurbitacin R −8.3 −7.9 −2.6 −1.3
Dihydrocucurbitacin 
B
−7.5 −7.2 −2.1 −1.8
Oleanolic acid −8.7 −7.5 1.3 −3.0
Partenolid −7.7 −8.1 −6.7 −7.3
Pseudopterosin −7.8 −7.5 −8.3 −9.0
Ursolic acid −7.8 −8.0 1.7 −3.6
Saponins
Kalopanaxsaponin −8.7 −7.7 9.1 −0.5
Loniseroside A −6.1 −7.8 −7.4 −6.5
Table 2. Binding energy values of natural compounds docked to target macromolecules.
Figure 2. Model interaction of tolfenamic acid, apigenin and epicatechin gallate with COX-2 binding site. Dark green: 
hydrogen bond; light green: van der Waals; red: electron donor-donor interaction; pink-violet: hydrophobic interaction.
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Figure 3. Model interaction of phospholipase native ligand, bilobetin, and ginkgetin. Dark green: hydrogen bond; light 
green: van der Waals; red: electron donor-donor interaction; pink-violet: hydrophobic interaction; brown: π-cation 
interaction.
Epicatechin gallate was reported to inhibit COX-2 enzyme [28]. In this study, epicatechin 
gallate also showed good interaction to COX-2 binding site, where hydrogen bond was 
formed between its phenolic groups and Tyr385A as well as Arg180A residues, in addition to 
hydrophobic interactions between the aromatic groups and Val349A, Val523A, Ala527A, and 
Leu531A. Berberine, the alkaloid used in study, showed lower affinity compared to native 
ligand. This result was in agreement with the fact that berberine does not interfere with COX 
enzyme activity [19].
5.2. Interaction to Phospholipase A2
Complex structure of PLA with 5-(2,5-dimethyl-3-thienyl)-1H-pyrazole-3-carboxamide, 
shows that the terminal amide group interacts with by hydrogen bonding with Asp47A and 
His46A, while hydrophobic interaction is formed between the thienyl pyrazole moiety and 
Leu5A [26]. Three biflavonoids, i.e., amentoflavone, bilobetin, and ginkgetin, were the ligands 
with the lowest binding energy, with the binding energy value being −9.0, −9.1, and −9.0 kcal/
mole respectively. Biflavanoids were repeatedly reported as PLA2 inhibitors [29–32].
The biflavonoids successfully docked into the PLA2 binding site (Figure 3). The compounds 
bind to the target via hydrogen bond with Leu29A residue, while hydrophobic interactions 
were formed between aromatic rings of biflavonoid with Ala2A, Leu5A as well as Ala6A. 
Hydrophobic pharmacophores of biflavonoids support the PLA2 inhibitory activity, due to 
interaction between substrate of PLA2 usually occurs at hydrophobic channel of the enzyme. 
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The π-cation interaction increases the affinity of biflavonoid, because the Ca2+ ion is important 
for the catalytic mechanism of PLA2 [33].
5.3. Interaction to NF-κB–inducing kinase (NIK)
Study about NIK inhibitory has been conducted with the analogs of imidazopyridinyl pyrim-
idinamine. The hydrogen bonds were formed between pyrimidinamine group and Glu470A 
as well as Leu 472A; furthermore, imidazopyridinyl pyrimidinamine ring was hydropho-
bically interacted to Val414A, Ala427A, Lys429A, Leu522A, and Cys533A. Interaction of 
π-sulfur was formed between pyrimidinamine ring and Met469A [34].
This study revealed that apigenin and luteolin, two flavonoid aglikons, had lowest binding 
energy values. This was in line with previous research reports that apigenin and luteolin 
inhibit activation of NF-πB [35–38].
The similarity of interaction model between native ligand and these flavonoids are presented 
in Figure 4. Hydrogen bond was formed between carbonyl group at C-ring (4-oxo) of flavo-
noid and Ser476A residue. Similar to the interaction model of native ligand, hydrophobic 
interactions were formed between aromatic rings of flavonoid with Val414A, Ala427A, and 
Leu522A residues. Interaction of π-sulfur was also formed between B-ring with Met469A 
residue. Additional hydrogen bonding was formed between hydroxyl groups of B-ring with 
Glu470A and Leu472A residues. This result concluded that o-catechol or p-hydroxy B-ring 
Figure 4. Model interaction of NIK native ligand, apigenin, and luteolin. Dark green: hydrogen bond; light green: van 
der Waals; red: electron donor-donor interaction; pink-violet: hydrophobic interaction; brown: π-sulfur interaction.
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Figure 5. Model interaction of NIK native ligand, quercetin, and bilobetin. Dark green: hydrogen bond; light green: van 
der Waals; red: electron donor-donor interaction; pink-violet: hydrophobic interaction.
was the pharmacophore group for NIK inhibitory activity, in addition to -oxo and planar 
aromatic ring of flavonoids.
5.4. Interaction to Interleukin-1 receptor-associated kinase-4 (IRAK-4)
The X-ray crystal structure of IRAK-4-inhibitor complex has been reported. The structure 
revealed that the carboxamide group and N-pyrazol contributed as hydrogen bond acceptor 
(interacted to Met265B and Lys213B, respectively). Furthermore, two aromatic rings acted as 
hydrogen bond donor increased the affinity to the target via hydrophobic interaction with 
Val200B, Ala211B, Val246B, Tyr262B, as well as Leu318B [39].
Among 40 natural compounds docked to IRAK-4, apigenin, bilobetin, curcumin, ginkgetin, 
quercetin, berberine, and pseudopterosin showed higher affinity compared to the native 
ligand. Quercetin was reported to show IRAK-4 inhibitory activity [40]. Affinity of querce-
tin to the binding site was supported by hydrogen bond between 4-hydroxy of B-ring with 
Lys213B and Glu233B residues, while the aromatic rings contributed by forming hydrophobic 
interaction with Val200B, Tyr262B, and Leu318B. Similar to the interaction model of native 
ligand to IRAK-4, aromatic rings of bilobetin also formed the hydrophobic interaction to 
Val200B, Tyr262B, and Leu318B residues of IRAK-4 (Figure 5).
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6. Conclusion
The docking results revealed that the highest affinity to the macromolecular targets (the low-
est binding energy values) and the consistency of interaction model were shown by the fla-
vonoids. Some terpenoids were identified to have potential inhibitor of phospholipase A2.
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